- 19 May 2022
- ICICIdirect Research
Ratnamani reports healthy performance for Q4FY22....
RATNAMANI - 3688 Change: 42.65 (1.17 %)News: For Q4FY22 RMTL reported topline of Rs.974 crore (up 40% YoY and 5% QoQ), higher than our estimate of Rs. 913 crore. EBITDA for the quarter was at Rs. 169 crore (up 6% YoY and 29% QoQ), higher than our estimate of Rs. 146 crore. Ensuing PAT for Q4FY22 was at Rs. 112 crore, up 2% YoY and 25% QoQ, higher than our estimate of Rs. 100 crore
Views: RMTL reported a healthy performance for Q4FY22. For the quarter, topline, EBITDA and PAT, all came in higher than our estimates. During Q4FY22 there was a healthy improvement in EBITDA margins on a sequential basis. For Q4FY22, RMTL’s EBITDA margin was at 17.3% compared to 14.1% in Q3FY22. On a QoQ basis, there was a healthy improvement in gross margins, which aided improvement in EBITDA margin on a sequential basis. Gross margins for Q4FY22 were at 34% compared to 29% in Q3FY22
Impact: Positive